These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6754212)

  • 1. Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting.
    Lucraft HH; Palmer MK
    Clin Radiol; 1982 Nov; 33(6):621-2. PubMed ID: 6754212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.
    Hutcheon AW; Palmer JB; Soukop M; Cunningham D; McArdle C; Welsh J; Stuart F; Sangster G; Kaye S; Charlton D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1087-90. PubMed ID: 6352278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
    Stuart-Harris RC; Mooney CA; Smith IE
    Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
    Heim ME; Queisser W; Altenburg HP
    Cancer Chemother Pharmacol; 1984; 13(2):123-5. PubMed ID: 6467496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.
    Joss RA; Galeazzi RL; Bischoff A; Do DD; Goldhirsch A; Brunner KW
    Cancer Chemother Pharmacol; 1982; 9(1):61-4. PubMed ID: 7139853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
    Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
    Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting.
    Heim ME; Romer W; Queisser W
    J Clin Pharmacol; 1981; 21(S1):86S-89S. PubMed ID: 7298877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
    Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
    J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].
    Heim ME; Queisser W
    Onkologie; 1982 Apr; 5(2):94-6. PubMed ID: 7048169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.
    Ruhlmann CH; Jahn F; Jordan K; Dennis K; Maranzano E; Molassiotis A; Roila F; Feyer P
    Support Care Cancer; 2017 Jan; 25(1):309-316. PubMed ID: 27624464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy.
    Cronin CM; Sallan SE; Gelber R; Lucas VS; Laszlo J
    J Clin Pharmacol; 1981; 21(S1):43S-50S. PubMed ID: 7028793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced emesis: effects of ondansetron.
    Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis.
    Stambaugh JE; McAdams J; Vreeland F
    J Clin Pharmacol; 1984; 24(11-12):480-5. PubMed ID: 6392353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonantradol for chemotherapy-induced emesis: phase I-II oral administration.
    Laszlo J; Lucas VS; Hanson DC; Cronin CM; Sallan SE
    J Clin Pharmacol; 1981; 21(S1):51S-56S. PubMed ID: 7298875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomiting.
    Colbert N; Izrael V; Lotz JP; Stoppa-Lyonnet D; Vannetzel JM; Pene F; Schlienger M; Laugier A
    J Clin Oncol; 1983 Oct; 1(10):635-9. PubMed ID: 6321674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral levonantradol in the control of cancer chemotherapy-induced emesis.
    Welsh J; Stuart F; Sangster G; Milstead R; Kaye S; Cash H; Charlton D; Calman K
    Cancer Chemother Pharmacol; 1983; 11(1):66-7. PubMed ID: 6684000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine.
    Archer CB; Amlot PL; Trounce JR
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):350-1. PubMed ID: 6402096
    [No Abstract]   [Full Text] [Related]  

  • 18. Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.
    Gerhartz HH; Binsack T; Hiller E
    Klin Wochenschr; 1983 Jul; 61(14):719-21. PubMed ID: 6350696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of radiation-induced nausea and vomiting.
    Abdelsayed GG
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):34-6. PubMed ID: 17379085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levonantradol in the treatment of nausea and vomiting caused by cytostatic drugs (author's transl) clinical studies].
    Higi M; Niederle N; Bremer K; Schmitt G; Schmidt CG; Seeber S
    Dtsch Med Wochenschr; 1982 Aug; 107(33):1232-4. PubMed ID: 7049655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.